08045804946
medisus.pharma007@gmail.com
Change Language
PAZINIB 400MG INJ

PAZINIB 400MG INJ

2500.0 INR/Number

Product Details:

  • Pacakaging (Quantity Per Box) 1 vial per box
  • Life Span 24 months from the date of manufacture
  • Origin of Medicine India
  • Packaging Type Vial
  • Brand Name PAZINIB 400MG INJ
  • Salt Composition Pazopanib Hydrochloride 400 mg
  • Indication Advanced renal cell carcinoma, advanced soft tissue sarcoma
  • Click to View more
X

PAZINIB 400MG INJ Price And Quantity

  • 2500.0 INR/Number
  • 1 Number
  • Oncology / Antineoplastic agents
  • Approved by Indian drug regulatory authority for specified indications
  • To be administered by healthcare professionals only
  • Hypersensitivity to pazopanib or any component of formulation
  • Clear, colorless to pale yellow solution
  • Regular liver function and blood pressure monitoring required
  • Prescription only
  • May include nausea, diarrhea, hypertension, hair color changes, liver enzyme elevation
  • Intravenous (IV)

PAZINIB 400MG INJ Product Specifications

  • India
  • Anticancer therapy (Tyrosine kinase inhibitor)
  • PAZINIB 400MG INJ
  • Vial
  • 1 vial per box
  • Antineoplastic (Anticancer)
  • Pazopanib Hydrochloride
  • 24 months from the date of manufacture
  • Parenteral (Injection)
  • 1 Vial
  • Store below 30C, protect from light and moisture
  • Adults with advanced renal cell carcinoma and advanced soft tissue sarcoma
  • As directed by the oncologist or physician
  • Administer intravenously as per prescribed schedule
  • Injection
  • Advanced renal cell carcinoma, advanced soft tissue sarcoma
  • Pazopanib Hydrochloride 400 mg
  • Adults
  • Oncology / Antineoplastic agents
  • Approved by Indian drug regulatory authority for specified indications
  • To be administered by healthcare professionals only
  • Hypersensitivity to pazopanib or any component of formulation
  • Clear, colorless to pale yellow solution
  • Regular liver function and blood pressure monitoring required
  • Prescription only
  • May include nausea, diarrhea, hypertension, hair color changes, liver enzyme elevation
  • Intravenous (IV)

PAZINIB 400MG INJ Trade Information

  • Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
  • 1000 Number Per Week
  • 2 Days
  • No
  • Central America, Asia, Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

  • Active Ingredient: Pazopanib 400 mg.
  • Mechanism of Action: The medication works by blocking specific proteins (tyrosine kinases, including VEGF receptors) that are involved in the growth and spread of cancer cells and the development of new blood vessels that feed tumors (angiogenesis). This action helps to slow down tumor growth and progression.
  • Indications:
    • First-line treatment for advanced renal cell carcinoma (a type of kidney cancer).
    • Treatment of certain subtypes of advanced soft tissue sarcoma (cancer in muscles, fat, blood vessels, or other supportive tissues) in adults who have received prior chemotherapy.
  • Administration: The tablets are for oral use only and should be swallowed whole with water, not crushed or chewed. They must be taken on an empty stomach, at least one hour before or two hours after a meal, to ensure proper absorption. It is usually taken once a day, at the same time each day.
  • Common Side Effects: Common side effects can include diarrhea, high blood pressure (hypertension), nausea, vomiting, decreased appetite, weight loss, headache, fatigue, and changes in hair color or skin pigmentation.
  • Important Precautions:
    • It may cause serious side effects, including liver damage, heart problems, bleeding issues, and gastrointestinal perforation. Regular monitoring of blood pressure, liver function, and blood cell counts is essential during treatment.
    • Grapefruit or grapefruit juice should be avoided while taking this medication.
    • It is not recommended during pregnancy or breastfeeding, and effective contraception must be used during treatment and for some time after the last dose.
Note: Pazinib is a prescription-only medication and should only be used under the strict guidance and supervision of a qualified healthcare professional.


Targeted Anticancer Therapy

PAZINIB 400MG INJ is designed to target specific cancer cells in advanced renal cell carcinoma and soft tissue sarcoma, addressing tumors with precision. As a tyrosine kinase inhibitor, it interferes with cancer growth pathways, aiming to slow disease progression and support improved patient outcomes.


Professional Administration and Monitoring

This medicine is exclusively administered via intravenous injection by trained healthcare professionals. Patients receive PAZINIB 400MG INJ in clinical facilities where they can be closely monitored for any adverse reactions or changes in liver function and blood pressure, ensuring safe and effective usage throughout the treatment course.


Safe Handling and Storage

Supplied as a clear, colorless to pale yellow solution in a single-use vial, PAZINIB 400MG INJ should be stored below 30C and kept away from light and moisture. The product remains effective for up to 24 months from its manufacturing date, provided storage instructions are followed carefully.

FAQ's of PAZINIB 400MG INJ:


Q: How is PAZINIB 400MG INJ administered to patients?

A: PAZINIB 400MG INJ is administered as an intravenous (IV) injection by a qualified healthcare professional, strictly in a clinical setting.

Q: What conditions is PAZINIB 400MG INJ recommended for?

A: It is prescribed for adults with advanced renal cell carcinoma and advanced soft tissue sarcoma as determined by an oncologist or physician.

Q: When should patients receive this injection?

A: The frequency and schedule of administration are decided by an oncology specialist based on the patient's treatment plan and response to therapy.

Q: Where can I access PAZINIB 400MG INJ treatment?

A: PAZINIB 400MG INJ is available only in hospitals or clinics under the supervision of healthcare professionals. It cannot be self-administered or purchased over the counter.

Q: What are the key benefits of PAZINIB 400MG INJ therapy?

A: This treatment aims to inhibit tumor growth by blocking specific enzymes involved in cancer progression, potentially improving disease outcome in advanced cancer cases.

Q: What are the possible side effects and monitoring requirements?

A: Possible side effects include nausea, diarrhea, hypertension, changes in hair color, and elevated liver enzymes. Regular monitoring of liver function and blood pressure is essential during treatment.

Q: Who should avoid taking PAZINIB 400MG INJ?

A: Individuals with a known hypersensitivity to pazopanib or its components should not use this medicine. Always inform your physician of any allergies before starting therapy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top